Repaglinide 0.5 tablet?

Repaglinide (0.5 mg tablet)
Repaglinide is a fast‑acting oral antidiabetic drug used to lower blood glucose in people with type 2 diabetes. The 0.5 mg tablet is one of the commonly prescribed strengths. Below is general information—if you have specific questions about your treatment, please discuss them with your prescribing clinician or pharmacist.

---

1. How It Works

• Mechanism: Repaglinide stimulates insulin release from the pancreas by closing ATP‑sensitive potassium channels in β‑cell membranes.
• Onset & Duration: Blood glucose levels start to fall within 30 min, peak at 1–3 h, and the effect lasts ~4 h.

2. Typical Dosing

Phase	Typical Dose	Frequency	Notes
Initial	0.5 mg after the first meal of the day	Once daily	Start low to gauge tolerance.
Maintenance	0.5 mg after each main meal	2–3 times daily	Total daily dose usually 1–3 mg.
Adjustment	Increase by 0.5 mg increments	Every 1–2 weeks	Aim for target fasting or post‑prandial glucose levels.

• Maximum dose: 6 mg/day (12 mg total in 24 h if needed).
• Meal‑timing: Take with or immediately after meals. Consistency in meal size and timing helps avoid hypoglycemia.

3. When to Take

• With Meals: Always take with a main meal to reduce the risk of hypoglycemia.
• Skipping Meals: If you miss a meal, skip the dose for that meal; do not double‑up.

4. Common Side Effects

• Hypoglycemia (most common) – especially if meals are skipped or if you’re on insulin/other sulfonylureas.
• Weight gain – due to increased insulin.
• Headache, nausea, dizziness, rash – usually mild.

5. Precautions & Contraindications

• Renal impairment: Dose adjustments may be needed.
• Hepatic impairment: Use cautiously; monitor liver function.
• Pregnancy & Lactation: Category C; discuss risks vs. benefits.
• Diabetic ketoacidosis: Use with caution; insulin may still be needed.
• Other sulfonylureas: Avoid concurrent use to prevent additive hypoglycemia.

6. Drug Interactions

Drug/Class	Effect on Repaglinide	What to Monitor
CYP2C9 inhibitors (e.g., fluconazole, amiodarone)	↑ plasma levels	Hypoglycemia risk ↑
CYP2C9 inducers (e.g., rifampin, phenytoin)	↓ plasma levels	Reduced glucose control
Fibrates	↑ repaglinide exposure	Hypoglycemia
Antacids with aluminum/magnesium	↓ absorption	Less glucose control
Other sulfonylureas	↑ risk of hypoglycemia	Avoid combination

7. Storage

• Keep in a cool, dry place (15–25 °C / 59–77 °F).
• Keep out of reach of children and pets.

8. Monitoring & Follow‑Up

• Blood glucose: Check fasting and post‑meal levels regularly.
• HbA1c: Every 3–6 months to assess overall control.
• Weight & waist circumference: Monitor for weight gain.
• Kidney & liver labs: As per your clinician’s schedule.

---

Quick Tips for Patients

1. Always take with food – even if you’re only eating a light snack.
2. Set alarms to remind you of dosing times, especially if you’re on multiple meals.
3. Check your blood glucose if you feel shaky, sweaty, or faint—these can be early signs of low blood sugar.
4. Keep an emergency “low‑glucose” kit (glucose tablets or juice) handy.
5. Notify your healthcare team if you notice any side effects, especially prolonged hypoglycemia, unexplained weight changes, or new rash.

---

When to Seek Medical Advice

• Severe hypoglycemia (confusion, seizures, loss of consciousness).
• Unexpected weight gain or fluid retention.
• Persistent nausea or vomiting that might reduce absorption.
• Any signs of liver dysfunction (jaundice, dark urine).

---

If you’re looking for more detailed information—such as how to adjust doses in renal insufficiency, how to use repaglinide with other diabetes medications, or the latest research—feel free to ask!